Literature DB >> 21284666

The unfolding web of innate immune dysregulation in alcoholic liver injury.

G Szabo1, P Mandrekar, J Petrasek, D Catalano.   

Abstract

Inflammatory cell and cytokine cascade activation is present in humans with alcoholic liver disease as well as in animal models of alcohol-induced liver damage. Gut-derived lipopolysaccharide (LPS), a ligand of the Toll-like receptor 4 (TLR4), plays a central role in triggering and maintaining activation of Kupffer cells in alcoholic hepatitis. In this mini-review, we describe molecular mechanisms that lead to increased inflammatory cell activation by alcohol and LPS and discuss the mechanism for activation in alcohol-exposed macrophages. In alcohol-induced liver disease we discuss the role of MyD88-independent but IRF3-mediated TLR4 signaling in alcohol-related liver inflammation and liver damage.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284666      PMCID: PMC3742381          DOI: 10.1111/j.1530-0277.2010.01398.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  38 in total

1.  Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice.

Authors:  T Uesugi; M Froh; G E Arteel; B U Bradford; R G Thurman
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 2.  Effect of alcohol consumption on the gut.

Authors:  Christiane Bode; J Christian Bode
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-08       Impact factor: 3.043

Review 3.  The feeding of alcohol in liquid diets: two decades of applications and 1982 update.

Authors:  C S Lieber; L M DeCarli
Journal:  Alcohol Clin Exp Res       Date:  1982       Impact factor: 3.455

4.  Alcoholic liver injury: experimental models in rats and baboons.

Authors:  C S Lieber; L M DeCarli
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

5.  Reduced early alcohol-induced liver injury in CD14-deficient mice.

Authors:  M Yin; B U Bradford; M D Wheeler; T Uesugi; M Froh; S M Goyert; R G Thurman
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients.

Authors:  Pedro Escoll; Carlos del Fresno; Lourdes García; Gema Vallés; Manuel J Lendínez; Francisco Arnalich; Eduardo López-Collazo
Journal:  Biochem Biophys Res Commun       Date:  2003-11-14       Impact factor: 3.575

7.  Alcohol and malnutrition in the pathogenesis of liver disease..

Authors:  C S Lieber
Journal:  JAMA       Date:  1975-09-08       Impact factor: 56.272

Review 8.  Recent insights into the role of the innate immune system in the development of alcoholic liver disease.

Authors:  Laura E Nagy
Journal:  Exp Biol Med (Maywood)       Date:  2003-09

Review 9.  Alcohol, injury, and cellular immunity.

Authors:  Kelly A Nordyke Messingham; Douglas E Faunce; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2002-11       Impact factor: 2.405

10.  Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.

Authors:  Andrei E Medvedev; Arnd Lentschat; Larry M Wahl; Douglas T Golenbock; Stefanie N Vogel
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

View more
  39 in total

1.  Effects of Clostridium difficile infection in patients with alcoholic hepatitis.

Authors:  Vinay Sundaram; Folasade P May; Vignan Manne; Sammy Saab
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-27       Impact factor: 11.382

2.  Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats.

Authors:  Ya-Ling Chen; Hsiang-Chi Peng; Xiang-Dong Wang; Suh-Ching Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

3.  Deletion of tumor progression locus 2 attenuates alcohol-induced hepatic inflammation.

Authors:  Camilla P Stice; Sajid Hussain; Chun Liu; Lynne M Ausman; Xiang-Dong Wang; Andrew S Greenberg
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

4.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 5.  Metabolic regulation of inflammasomes in inflammation.

Authors:  Qiuli Yang; Ruichen Liu; Qing Yu; Yujing Bi; Guangwei Liu
Journal:  Immunology       Date:  2019-04-08       Impact factor: 7.397

Review 6.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

7.  Alcoholic liver disease - Hepatocellular carcinoma transformation.

Authors:  Samuel W French; James Lee; Jim Zhong; Timothy R Morgan; Virgil Buslon; William Lungo; Barbara A French
Journal:  J Gastrointest Oncol       Date:  2012-09

8.  MicroRNAs in Liver Disease: Bench to Bedside.

Authors:  Nihar Shah; James E Nelson; Kris V Kowdley
Journal:  J Clin Exp Hepatol       Date:  2013-09-17

Review 9.  Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.

Authors:  Won Kim; Dong Joon Kim
Journal:  World J Hepatol       Date:  2014-10-27

Review 10.  Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives.

Authors:  Juan P Arab; Marco Arrese; Vijay H Shah
Journal:  Hepatol Res       Date:  2020-01-13       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.